Question to the Department of Health and Social Care:

To ask Her Majesty's Government what plans they have to secure stocks of AstraZeneca's treatment AZD7442 as a prophylactic preventative therapy against COVID-19 infection.

We are unable to provide the information requested as it is commercially sensitive.

The Department published a Prior information Notice in Find a Tender Service on 5 October 2021 inviting suppliers to submit an Expression of Interest on neutralising antibody treatments they are developing for treating and preventing COVID-19. The engagement enables the Department to monitor development of all neutralising monoclonal antibodies for treatment and prevention of COVID-19.